GLP-1s Could Slow Cancer Growth, Says New Study
Tracking Apps and Devices There are apps specifically designed for users of GLP-1 medications like semaglutide and tirzepatide
Additionally, a 2018 study suggested potential pancreatic cancer protection in individuals with type 2 diabetes who used incretin-based therapies over an extended period
For example, statins like atorvastatin and lovastatin may show delayed peak levels, but overall exposure remains unaffected
Tirzepatide works by targeting both GLP-1 and GIP receptors, resulting in greater weight loss and better glucose lowering than medications that target GLP-1 alone, said Isaacs
The first-month discount is attractive, but the ongoing cost is what determines actual affordability over a treatment course that typically runs 6 to 12 months or longer